Business
KRTL Holding Highlights SIGMA’s 50-Year Legacy of Innovation, Quality, and Community Leadership in Bolivia
KRTL Holding Highlights SIGMA’s 50-Year Legacy of Innovation, Quality, and Community Leadership in Bolivia.
About this update from Krtl Holding Group, Inc
[{"type":"text","content":"KRTL\r\nHolding Group Inc. (OTC: KRTL) (\"KRTL Holding\" or the\r\n\"Company\") is pleased to recognize and celebrate the legacy of\r\nIndustria Químico-Farmacéutica SIGMA Corp SRL (\"SIGMA\"), its Bolivian\r\npartner and a cornerstone of the Latin American pharmaceutical landscape for\r\nnearly five decades.\r\nFounded\r\nin 1976, SIGMA has established itself as a national leader in the research,\r\nmanufacturing, and distribution of pharmaceutical, nutraceutical, and biosafety\r\nproducts. With more than 50 years of experience and a reputation built on\r\nGMP-certified quality and social responsibility, SIGMA continues to play a\r\ncritical role in strengthening Bolivia's healthcare infrastructure while\r\nexpanding its reach into international markets.\r\n\"SIGMA\r\nis more than a manufacturer—it is a pillar of health and innovation in\r\nBolivia,\" said Cesar Herrera, CEO of KRTL Holding Group Inc. \"Their\r\nlegacy of compliance, quality, and public impact aligns with KRTL Biotech’s\r\nmission to advance science-based solutions for global health.\"\r\nOrigins, Legacy, and Modern Infrastructure\r\nSIGMA’s\r\nroots trace back to its early leadership in pharmaceutical distribution through\r\nWilstermann y CIA LTDA, a company that served as the exclusive Bolivian\r\nrepresentative for major U.S. and European pharmaceutical brands including UCB\r\nLabs (Belgium), William H. Rorer Inc. (USA), Mepha Labs, Medinova Labs\r\n(Switzerland), Siegfried Labs (Netherlands), POEN Labs (Argentina), and Saval\r\nLabs (Chile). This foundation established SIGMA as a key gateway for innovation\r\nin Bolivia’s pharmaceutical market—introducing groundbreaking products such as\r\nZyrtec, Maalox, Camalox, Ananase, Nootropil, Trabit, and B-Alert.\r\nIn 1996, the company entered a new era when it\r\nwas acquired by the board members of Wilstermann y CIA LTDA, that allowed to expand operations into\r\nmanufacturing and importation. Notably, SIGMA began producing and distributing\r\nselect products for Johnson & Johnson, such as Biafine.\r\nToday,\r\noperating out of a modern 15,000 m² facility in the Santivañez Industrial Park\r\nin Cochabamba, SIGMA's production plant is equipped with European-standard\r\ntechnology and adheres to both national and international regulatory standards.\r\nThis robust infrastructure supports the company’s dive...